Category
117 releases
Vector's cGMP-manufactured Rx peptides, independently tested and Rx-labeled for physician use, are built to the standards of safety, quality and…
FDA announces the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s…
On International LGS Awareness Day™, November 1, families ask the world to see LGS through Faces of LGS: Real Stories, Real Research, with Luminary…
Dr. Umar and colleagues outline how individualized assessment may reveal additional graft options while identifying areas to avoid MANHATTAN BEACH,…
In this free webinar, learn how evidence-based trial design can help address remaining gaps in pediatric and adolescent obesity research. The…
Company announces FDA 510(k) clearance of the device for use in pediatric and adult patients. CORE 300 is the first stethoscope to integrate…
Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced today that the European Commission…
Expands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S. FDA clearance of…
Multi-center, randomized controlled study will evaluate the safety and preliminary efficacy of investigational injectable rhPDGF-BB in up to 75…
Publication of first ever head-to-head comparison of gut microbiome changes associated with novel oral preclinical PolC (pol IIIC*) inhibitors to…
Research highlights Nu-3's rapid bactericidal activity against clinically relevant resistant pathogens and its potential as a topical treatment for…
Shu Jun Zhen, 31, of New York, was sentenced today in the Western District of North Carolina to nine years in prison and ordered to forfeit nearly…
SonoClear AS today announced that its 510(k) submission for the SonoClear® System, an innovative acoustic coupling fluid, has been accepted for…
FDA today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV)…
Today, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per…
The U.S. Food and Drug Administration today released final guidance establishing a clear framework for how drug companies can develop, distribute,…
The U.S. Food and Drug Administration today granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab-gxly) that may…
